Gerald Clarke | 03/05/2014
Where can companies go wrong in their relationship with a CMO and what have been the major changes in these relationships in recent years? We spoke with Jim Browne, former Director of External Supply at GlaxoSmithKline and currently Director at JTB Consultancy Ltd to find out the answers to these questions. Jim also talks about they key to maintaining these relationships and using KPIs to assess the success of a project.
To continue reading this story Click Here
RECOMMENDED
Pharma Contract Manufacturing 2025
2025-03-03
Digital Transformation in Pharma: Navigating CMO Partnerships and Supply Chain Resilience
2025-01-22
Upcoming Events
AI for Pharma & Healthcare
23 - 25 September, 2025
Amsterdam
Register Now |
View Agenda |
Learn More